Oncternal Therapeutics to Provide Business Update and
SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage
Globe Newswire3-03-2023, 05:36
Armstrong International Secures Funding from European Commission’s Innovation Fund to Support Factory Expansion in Herstal, Belgium 30-10-2024, 19:00